These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Prospective randomized study of quadruple versus triple therapy in long-term kidney allografts. Fruchaud G; Buisson C; Abbou C; Desvaux D; Baron C; Benmaadi A; Chopin D; Bourgeon B; Dahmane D; Rostoker G; Weil B; Lang P Transplant Proc; 1996 Oct; 28(5):2819. PubMed ID: 8908077 [No Abstract] [Full Text] [Related]
30. Use of antilymphocyte induction therapy in liver transplantation: A European perspective. Langrehr JM; Neuhaus PJ Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S71-84. PubMed ID: 10431020 [No Abstract] [Full Text] [Related]
31. Quadruple immunosuppression including a new IL-2-receptor antibody and the incidence of infections after liver transplantation. Raakow R; Steffen R; Knoop M; Blumhardt G; Lemmens P; Wiens M; Keck H; Neuhaus P Transpl Int; 1992; 5 Suppl 1():S168-9. PubMed ID: 14621765 [TBL] [Abstract][Full Text] [Related]
32. Randomized trial of induction immunosuppression with anti-IL2-R monoclonal antibody 33B3.1 and rabbit antithymocyte globulin following simultaneous pancreas and kidney transplantation. Cantarovich D; Paineau J; Le Mauff B; Karam G; Yaques Y; Hourmant M; Dantal J; Baatard R; Soulillou JP Transplant Proc; 1992 Jun; 24(3):911. PubMed ID: 1604665 [No Abstract] [Full Text] [Related]
33. Immunosuppression induction with daclizumab and antithymocyte globulin in cardiac transplantation: clinical experience with 8 cases. Huang XS; Chen DZ; Chen LW; Li ZQ; Liao CX Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):126-8. PubMed ID: 14965807 [TBL] [Abstract][Full Text] [Related]